This protocol describes a co-culture system for the in vitro differentiation of mouse embryonic stem cells into hepatocyte-like cells. Differentiation involves four steps: (i) formation of embryoid bodies (EB), (ii) induction of definitive endoderm from 2-d-old EBs, (iii) induction of hepatic progenitor cells and (iv) maturation into hepatocyte-like cells. Differentiation is completed by 16 d of culture. EBs are formed, and cells can be induced to differentiate into definitive endoderm by culture in Activin A and fibroblast growth factor 2 (FGF-2). Hepatic differentiation and maturation of cells is accomplished by withdrawal of Activin A and FGF-2 and by exposure to liver nonparenchymal cell-derived growth factors, a deleted variant of hepatocyte growth factor (dHGF) and dexamethasone. Approximately 70% of differentiated embryonic stem (ES) cells express albumin and can be recovered by albumin promoter-based cell sorting. The sorted cells produce albumin in culture and metabolize ammonia, lidocaine and diazepam at approximately two-thirds the rate of primary mouse hepatocytes.
INTRODUCTION

Protocols have been developed to differentiate and enrich various cell types from embryonic stem (ES) cells. Previous studies indicate
that ES cells can be differentiated into hepatocyte-like cells [1] [2] [3] [4] [5] [6] . ES cell-derived hepatocytes would be useful as a source of material for cell transplantation, bioartificial liver (BAL) support devices, studies on hepatocyte biology and hepatitis viruses and for drug testing. Methods for hepatic differentiation of ES cells can be divided into those involving spontaneous differentiation and those involving directed differentiation. Spontaneous differentiation of ES cells can be accomplished in serum-containing medium through the formation of embryoid bodies (EB)-containing cells representing ectoderm, mesoderm and endoderm lineages. Subsequent inoculation of the EB-derived cells on adherent matrix substrates allows spontaneous differentiation, producing occasional hepatocyte-like cells 3, 6 . In vivo differentiation of mouse ES cells has also been accomplished by transplantation into the livers of carbon tetrachloride-treated mice. ES cell-derived hepatocyte precursors have been recovered from the intrahepatic teratomas that form following injury to the liver and ES cell engraftment 1 . These protocols have contributed to our understanding of factors affecting hepatic differentiation by mouse ES cells.
While a number of in vitro differentiation protocols (using retinoic acid (RA), hepatocyte growth factor (HGF), fibroblast growth factor-1 (FGF-1), FGF-4, oncostatin M and various matrix substrates 2 ) have successfully generated hepatocyte-like cells, none has been shown to produce cells with a mature phenotype. The recent report of a technique for efficient generation of definitive endoderm from ES cells by culture in lower concentrations of serum and Activin A [7] [8] [9] has been an important advance for subsequent production of hepatocyte-like cells. We have found that induction of definitive endoderm from ES cells was a necessary step for subsequent hepatic differentiation in vitro. Hepatic differentiation of stem cells and maturation of hepatic progenitors occurs in vitro after co-culture with damaged slices of liver or culture in medium conditioned by nonparenchymal liver cells [10] [11] [12] [13] . Reproducibility, however, has been limited.
We devised a strategy for differentiation of ES cells into hepatocyte-like cells using a four-step differentiation protocol: (i) generation of EBs; (ii) induction of definitive endoderm from 2-d-old EBs by growth in Activin A and FGF-2; (iii) induction of hepatic progenitors by co-culture with human liver nonparenchymal cell lines (human liver endothelial (TMNK-1) 14 , stellate (TWNT-1) 15 and cholangiocyte (MMNK-1) 16 cell lines) and a deleted variant of HGF (dHGF); and (iv) maturation into hepaticlike cells by culture in DMSO and dexamethasone (Fig. 1) . This in vitro differentiation system leads to a modest degree of hepatocyte-specific gene expression after 7 d of culture and a significantly increased degree of hepatocyte-specific gene expression by 14 d of culture. After completion of the differentiation program, 68.7% ± 4.8% (standard deviation) of cells express albumin. At day 7 of the differentiation program, 48.4 ± 2.4% of the cells co-express alpha-fetoprotein (AFP), while on day 14 of the program only 21.3 ± 3.7% of the cells co-express AFP. Differentiated ES cells secrete albumin; metabolize ammonia, lidocaine and diazepam; contain glycogen rosettes and express no pancreatic exocrine proteins. Mice with liver failure treated with an implantable liver assist device containing the ES cell-derived hepatocytes survived better and had improved liver function earlier than mice treated with the implantable assist device containing control cells 17 . The present hepatic differentiation strategy appears to require further optimization to eliminate AFP-positive cells and to produce a more homogeneous population of hepatocyte-like cells. It is possible that our protocol could be modified to obtain other cellular phenotypes by changing the culture conditions to include other types of cells. . Inverted confocal laser-scanning microscope (LSM510; Carl Zeiss) . ImageJ software (US National Institutes of Health) . Fluorocytometer (650-10S, Hitachi)
MATERIALS
REAGENT SETUP m CRITICAL All reagents should be freshly prepared. Plasmid pALB-GFP This vector contains the gene encoding enhanced GFP driven from the human albumin (ALB) promoter. The DNA sequence and map for pALB-GFP are shown in Supplementary Figures 1 and 2 . The pALB-GFP plasmid is available from D. Zhao (Centre for Regenerative Medicine, GU507, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB UK; e-mail: dzhao@staffmail.ed.ac.uk). Mouse ES cell culture medium Complete ES culture medium (DMEM) (Specialty Media) containing 15% FBS, 1% nonessential amino acid (1:100 dilution of the 100Â stock), 1% nucleosides (1:100 dilution of the 100Â stock), 2-mercaptoethanol (110 mM), 1% penicillin/streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin), 1% glutamic acid (1:100 dilution of the 100Â stock) and 500 U/ml leukemia inhibitory factor. Mouse feeder cell medium DMEM (Sigma) containing 10% FBS, 4,500 mg/l glucose, 2 mM L-glutamine, 1% penicillin/streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin). Human liver cell line medium containing mitomycin C DMEM (Sigma) containing 10% FBS, 4,500 mg/l glucose, 2 mM L-glutamine, 1% penicillin/ streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin) and mitomycin C (10 mg/ml). Embryoid body formation medium DMEM-F12 (Gibco) containing 15% FBS, 1% nonessential amino acids (1:100 dilution of the 100Â stock), 1% nucleosides (1:100 dilution of the 100Â stock), 1% penicillin/streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin) and 1% glutamic acid (1:100 dilution of the 100Â stock). Differentiation medium I DMEM-F12 (Gibco) containing 1% FBS, 1% nonessential amino acids (1:100 dilution of the 100Â stock), 1% nucleosides (1:100 dilution of the 100Â stock), 1% penicillin/streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin), 1% glutamic acid (1:100 dilution of the 100Â stock), 3% BSA, 100 ng/ml FGF-2 and 100 ng/ml Activin-A. (1:100 dilution of the 100Â stock), 1% penicillin/streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin), 1% glutamic acid (1:100 dilution of the 100Â stock), 100 ng/ml dHGF or 10-50 ng/ml HGF and 1% DMSO. Differentiation medium III DMEM-F12 (Gibco) containing 10-15% FBS, 1% nonessential amino acid (1:100 dilution of the 100Â stock), 1% nucleosides (1:100 dilution of the 100Â stock), 1% penicillin/streptomycin (100 units/ml penicillin, 0.1 mg/ml streptomycin), 1% glutamic acid (1:100 dilution of the 100Â stock), 100 ng/ml dHGF and 10 À7 M dexamethasone.
Cell lines The TMNK-1 cell line was generated from commercially available normal human liver endothelial cells (Dinippon Sumitomo Parma, cat. no. CS-ABI-566) by transduction with recombinant retrovirus vectors SSR#69, which transfers expression of the simian virus 40 large T antigen (SV40T), and SSR#197, which transfers human telomerase reverse transcriptase (hTERT) expression. The TWNT-1 cell line was generated from human LI 90 cells, which were derived from a mesenchymal liver tumor removed from a 55-year-old Japanese woman. The cells were transduced with the SSR#197 recombinant retroviral vector, which transfers human telomerase reverse transcriptase (hTERT) expression. The MMNK-1 cell line was generated from OUMS-21 cells, which were derived from human fetal liver by transduction with the SSR#197 recombinant retrovirus vector (hTERT). Generation of embryoid bodies from mouse ES cell cultures 7| Trypsinize ES cells as described in Steps 3-6 above, except resuspend cells in 2 ml of EB formation medium at the end.
Transfer the single-cell solution to one well of an ultra-low attachment plate. Add 2 ml of EB formation medium to each well to give a total volume of 4 ml per well. Depending on the cell density of the ES cells, the split ratio for this procedure can vary. In our hands, a cell suspension concentration of 1.0 Â 10 5 cells/ml medium is suitable for hepatic differentiation.
8| Optionally, change the EB formation medium to fresh medium after 24 h. To do this, transfer the EBs into a 15-ml tube and centrifuge at 100g for 3 min. Aspirate the supernatant, replace with fresh EB formation medium (4 ml/well) and transfer to six-well ultra-low attachment plates for embryoid body formation. After 48 h of culture in suspension, check if ES cells have formed floating aggregates known as embryoid bodies (EBs). m CRITICAL STEP A low number of cells per well leads to small-size EBs with insufficient differentiation capacity. An excessive number of ES cells per well results in large EBs with apoptotic cells. The number of mouse ES cells should be adjusted per well. EBs are formed before treatment with Activin A to reduce the cytotoxicity associated with treatment with low serum and Activin A. This cytotoxicity occurs even in the presence of high concentrations of FGF-2 (100 ng/ml). ES-derived hepatocytes also have better hepatocyte-like function when EBs are formed first.
9|
Transfer the EBs into a 15-ml tube and let aggregates settle for 5 min, or centrifuge at 100g for 3 min. Aspirate the supernatant, replace with fresh differentiation medium (2 ml/well) and transfer to six-well plates for further differentiation. when using PAU-coated PTFE, but Matrigel can be also used because it is a major component of the extracellular matrix. We believe that the human liver nonparenchymal cell lines secrete necessary matrix components into the medium for hepatic differentiation.
11| After transferring EBs to individual wells of six-well plates, add 2 ml of differentiation medium I for 3 d. If clusters of cells are not attached, change medium to fresh medium after the second day (optional). Collect the medium into a 15-ml tube and let aggregates settle for 5 min. Aspirate the supernatant, replace with fresh differentiation medium and plate again in the same well. m CRITICAL STEP FBS is needed for cell attachment so you can culture EBs for 8 h in 2 ml of differentiation medium I supplemented with 10% FBS on Matrigel before the next step. Remove FBS after cell attachment. m CRITICAL STEP Individual EBs should have sufficient space to allow cells to proliferate and to migrate for several days after plating. If the cell density is too high, it might lead to insufficient differentiation owing to metabolic starvation, cell necrosis and/or apoptosis or might lead to formation of tissue-like aggregates at the end of the differentiation protocol that will be very difficult to dissociate into a single-cell suspension.
Induction of hepatic progenitor cells (expressing both albumin and AFP) and maturation into hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines 12| Prepare human liver nonparenchymal cell lines [14] [15] [16] , which can be maintained in T75 tissue culture flasks in 10 ml of DMEM and 10% FBS. Passage confluent cultures every week, and change the medium every 3 d.
13|
Before co-culture, treat confluent cell lines with human liver cell line medium containing mitomycin C for 2 h. Then wash cells two or three times with PBS. Albumin  5¢-GACAAGGAAAGCTGCCTGAC-3¢  AJ011413  5¢-TTCTGCAAAGTCAGCATTGG-3¢  CK 18  5¢-CGATACAAGGCACAGATGGA-3¢  XM356490  5¢-CTTCTCCATCCTCCAGCAAG-3¢  FOXA2  5¢-TATTGGCTGCAGCTAAGCGG-3¢  UO4197  5¢-GACTCGGACTCAGGTGAGGT-3¢  SOX17  5¢-TTTGTGTATAAGCCCGAGATGG-3¢  NM011441  5¢-AAGATTGAGAAAACACGCATGAC-3¢  CYP 7A1 5¢ Table 2 ). (iii) Rinse cover slips with PBS at RT for 5 min. (iv) Apply second antibody (depending on the primary antibody; see Table 3 ), diluted in PBS containing 0.5% BSA, in a humidified chamber at 37 1C for 45 min. 
TIMING
See Figure 1 for a timeline for production of hepatocyte-like cells (which takes 16 d The whole detection process must be completed in under 30 min. Increase sample volume to 2 ml, check that the cells are 100% confluent or, as an alternative, slightly increase the amount of biotin antibody used (diluted up to 2 ml) a marker for undifferentiated ES cells, HNF4 and AFP (Fig. 2) should be expressed in EB cells, indicating early development of primitive endoderm in 2-d-old EBs. These results should be consistent with RT-PCR data from D0 cells.
RT-PCR characteristics of differentiating mouse ES-derived hepatocytes (Fig. 2k ) from day 0 to day 7 of differentiation should reveal transient expression of the primitive streak gene brachyury, indicating induction of mesendoderm, and induction of markers of definitive endoderm (GSC, Cdh3, FOXA1 and Sox17). Additionally, expression of GATA-4 and HNF-6, common hepatic/pancreatic transcription factors, is induced and maintained until the end of the differentiation protocol (day 14). This suggests that, in addition to differentiation of hepatic lineage cells, the current protocol might also generate other progenitor cell types.
In order to verify induction of definitive endoderm by treatment with Activin A and FGF-2 for subsequent hepatic differentiation (Fig. 2l) , we cultured cells for 3 d with Activin-A only, FGF-2 only, or with neither Activin-A nor FGF-2. Cells were then cultured as outlined above, with dHGF, DMSO and DEX. RT-PCR gene expression on days 7 and 14 of liver-specific ES cell differentiation should show that Activin-A is essential for initiation of hepatic differentiation.
Protein analysis of the culture medium from human liver nonparenchymal cell lines See Figure 3 for sample results. Cytokines and growth factors produced by the human liver nonparenchymal cell lines should be analyzed to verify that the conditioned medium contains factors needed for hepatic maturation. A protein array study should be performed for this purpose (Fig. 3a-d) , and the endothelial cell line (TMNK-1), cholangiocyte cell line (MMNK-1) and stellate approximately 48.4 ± 2.4% of differentiating cells. By day 14 of hepatic differentiation, 73.0 ± 6.9% of the cells should express ALB, but only approximately 21.3 ± 3.7% should coexpress AFP (Fig. 4a-d) . These results should correlate with the data obtained by cell sorting after differentiated cells are transduced with a plasmid containing GFP cDNA under the control of the albumin promoter (pALB-GFP); by day 14 of hepatic differentiation, approximately 68.7 ± 4.8% of cells should be GFP positive (Fig. 4e) . To show the functional status of the differentiated cells, it should be possible to detect albumin secretion and metabolism of ammonia sulfate, lidocaine and diazepam by mouse ES cell-derived hepatocytes and by mouse primary hepatocytes (Fig. 4f-i) . Mouse ES-derived hepatocytes co-cultured with human liver nonparenchymal cell lines showed higher metabolic capacity compared with mouse ES-derived hepatocytes differentiated without co-culture (see ref. 17 and Fig. 3 ).
Immunofluorescence analysis for pancreatic exocrine factors and hormones by ES-derived cells See Figure 5a -d for sample results. Expression of pancreatic exocrine factors and hormones by mouse ES-derived hepatocytes should be performed to characterize the specificity of the differentiation process. Mouse ES-derived hepatocytes should not express gastrin, which is normally expressed by mucosal cells in the gastric antrum, or secretin, which is normally expressed by S cells in the proximal small intestine. Similarly, pancreatic amylase should not be detected in mouse ES-derived hepatocytes, as determined by immunofluorescence. In addition, the production of serine proteases, cysteine proteases, metalloproteases or aspartic proteases should not be detected in 24-h cultures of either mouse ES-derived hepatocytes or primary hepatocytes (Fig. 5 ).
Outlook
Our differentiation system represents a basic protocol to coax mouse ES cells into hepatic lineage cells, and it is amenable to additional strategies for improving in vitro differentiation. This protocol provides a road map for differentiating human ES cells into hepatocytes. The present experimental setup may have applications in addition to those described here. For example, this protocol could be modified to explore induction of different hepatic lineage cells. 
